The influence of serum apolipoprotein E concentration and polymorphism on serum lipid parameters in hemodialysis patients

American Journal of Kidney Diseases

Volumn 44, Issue 2, 2004, Pages 300-308

  Liberopoulos, Evagelos N ^a   Miltiadous, George A ^a   Cariolou, Marios ^c   Tselepis, Alexandros D ^b   Siamopoulos, Kostas C ^a   Elisaf, Moses S ^a,b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

Author keywords

Apolipoprotein E (ApoE); hemodialysis (HD); kidney; lipids; lipoproteins; renal disease; renal failure

Indexed keywords

APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL;

AGED; ALLELES; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4; APOLIPOPROTEINS B; APOLIPOPROTEINS E; BLOOD GLUCOSE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; KIDNEY FAILURE, CHRONIC; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RENAL DIALYSIS; TRIGLYCERIDES;

EID: 3242696368     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2004.04.035     Document Type: Article

References (39)

1. Mahley R.W. Apolipoprotein E Cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630
2. Yamamoto T., Bujo H. Close encounters with apolipoprotein E receptors. Curr Opin Lipidol. 7:1996;298-302
3. Utermann G. Apolipoprotein E polymorphism in health and disease. Am Heart J. 113:1987;433-440
4. Utermann G., Kindermann H., Kaffarnic H., Steinmetz A. Apolipoprotein E phenotypes and hyperlipidemia. Hum Genet. 65:1984;232-236
5. Mahley R.W., Huang Y. Apolipoprotein E From atherosclerosis to Alzheimer's disease and beyond. Curr Opin Lipidol. 10:1999;207-217
6. Salah D., Bohnet K., Gueguen R., Siest G., Visvikis S. Combined effects of lipoprotein lipase and apolipoprotein E polymorphisms on lipid and lipoprotein levels in the Stanislas cohort. J Lipid Res. 38:1997;904-912
7. Xia Y., Sass C., Shen X., Siest G., Visvikis S. Associations of apolipoprotein E concentration and polymorphism with lipids and apolipoprotein levels in Chinese from Beijing and Shanghai. Clin Chem Lab Med. 38:2000;655-659
8. Schiele F., De Bacquer D., Vincent-Viry M., et al. Apolipoprotein E serum concentration and polymorphism in six European countries The ApoEurope Project. Atherosclerosis. 152:2000;475-488
9. Haddy N., De Bacquer D., Chemaly M.M., et al. The importance of plasma apolipoprotein E concentration in addition to its common polymorphism on inter-individual variation in lipid levels Results from ApoEurope. Eur J Hum Genet. 10:2002;841-850
10. Elisaf M.S., Bairaktari H.T., Tziallas C.S., Germanos N.K., Siamopoulos K.C. Atherogenic lipid and lipoprotein parameters in hemodialysis patients. Dial Transplant. 24:1995;642-650
11. Attman P.O., Samuelsson O., Johansson A.C., Moberly J.B., Alaupovic P. Dialysis modalities and dyslipidemia. Kidney Int. (Suppl 84):2003;S110-S112
12. Elisaf M., Mikhailidis D.P., Siamopoulos K.C. Dyslipidaemia in patients with renal diseases. J Drug Dev Clin Pract. 7:1996;331-348
13. Guz G., Ozdemir F.N., Sezer S., et al. Effect of apolipoprotein E polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patients. Am J Kidney Dis. 36:2000;826-836
14. Feussner G., Wey S., Bommer J., Deppermann D., Grutzmacher P., Ziegler R. Apolipoprotein E phenotypes and hyperlipidemia in patients under maintenance hemodialysis. Hum Genet. 88:1992;307-312
15. Imura T., Kimura H., Gejyo F. Apolipoprotein E phenotypes in hemodialysis patients. Kidney Int. (Suppl 71):1999;S245-S247
16. Oda H., Yorioka N., Ueda C., Nishida Y., Yamakido M. Apolipoprotein E phenotype and renal disease. Contrib Nephrol. 120:1997;22-29
17. Lim P.S., Liu C.S., Hong C.J., Wei Y.H. Prevalence of apolipoprotein E genotypes in ischaemic cerebrovascular disease in end-stage renal disease patients. Nephrol Dial Transplant. 12:1997;1916-1920
18. Liberopoulos E.N., Elisaf M.S. Could apolipoprotein E polymorphisms be hidden behind the relation between bone mineral density and atherosclerosis in hemodialysis patients? Osteoporos Int. 14:2003;957
19. Liberopoulos E., Siamopoulos K., Elisaf M. Apolipoprotein E and renal disease. Am J Kidney Dis. 43:2004;223-233
20. Bairaktari E., Elisaf M., Tzallas C., et al. Evaluation of five methods for determining low-density lipoprotein cholesterol (LDL-C) in hemodialysis patients. Clin Biochem. 34:2001;593-602
21. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res. 31:1990;545-548
22. Kesaniemi Y.A., Ehnholm C., Miettinen T.A. Intestinal cholesterol absorption efficiency in man is related to apolipoprotein E phenotype. J Clin Invest. 80:1987;578-581
23. Dong L.M., Weisgraber K.H. Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J Biol Chem. 271:1996;19053-19057
24. Dallongeville J., Lussier-Cacan S., Davignon J. Modulation of plasma triglyceride levels by apoE phenotype A meta-analysis. J Lipid Res. 33:1992;447-454
25. Joven J., Vilella E. The influence of apoprotein ε2 homozygosity on nephrotic hyperlipidemia. Clin Nephrol. 48:1997;141-145
26. Feussner G., Wingen A.M., Ziegler R. Type III hyperlipoproteinemia in a child with hemolytic uremic syndrome. Metabolism. 39:1990;1196-1199
27. Milionis H.J., Elisaf M.S., Tselepis A., Bairaktari E., Karabina S.A., Siamopoulos K.C. Apolipoprotein (a) phenotypes and lipoprotein(a) concentrations in patients with renal failure. Am J Kidney Dis. 33:1999;1100-1106
28. De Knijff P., Kaptein A., Boomsma D., Princen H.M.G., Frants R.R., Havekes L.M. Apolipoprotein E polymorphism affects plasma levels of lipoprotein(a). Atherosclerosis. 90:1991;169-174
29. Attman P-O, Samuelsson O., Moberly J., et al. Apolipoprotein B-containing lipoproteins in renal failure The relation to mode of dialysis. Kidney Int. 55:1999;1536-1542
30. Mensenkamp A.R., Jong M.C., Van Goor H., et al. Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver. J Biol Chem. 274:1999;35711-35718
31. Huang Y., Liu X.Q., Rall S.C. Jr, et al. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia. J Biol Chem. 273:1998;26388-26393
32. Bohnet K., Pillot T., Visvikis S., Sabolovic N., Siest G. Apolipoprotein (apo) E genotype and apoE concentration determine binding of normal very low density lipoproteins to HepG2 cell surface receptors. J Lipid Res. 37:1996;1316-1324
33. Eto M., Saito M., Okada M., et al. Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients. Am J Kidney Dis. 40:2002;243-251
34. Kimura H., Suzuki Y., Gejyo F., et al. Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM. Am J Kidney Dis. 31:1998;666-673
35. Chew S.T.H., Newman M.F., White W.D., et al. Preliminary report on the association of apolipoprotein E polymorphisms, with postoperative peak serum creatinine concentrations in cardiac surgical patients. Anesthesiology. 93:2000;325-331
36. Bayes B., Pastor M.C., Lauzurica R., et al. Apolipoprotein E alleles, dyslipemia and kidney transplantation. Transplant Proc. 34:2002;373
37. Liberopoulos E.N., Miltiadous G.A., Cariolou M., Kalaitzidis R., Siawopoulous K.C., Elisaf M.S. Influence of apolipoprotein E polymorphisms on serum creatinine levels and predicted glomerular filtration rate in healthy subjects. Nephrol Dial Transplant. 2004;. (in press)
38. Kervinen K., Savolainen M.J., Salokannel J., et al. Apolipoprotein E and B polymorphisms - Longevity fac-tors assessed in nonagenarians. Atherosclerosis. 105:1994;89-95
39. Olmer M., Renucci J.E., Planells R., Bouchouareb D., Purgus R. Preliminary evidence for a role of apolipoprotein E alleles in identifying haemodialysis patients at high vascular risk. Nephrol Dial Transplant. 12:1997;691-693